I have reread this headline many times and knowing how important the wording of this is have come to the conclusion that we have a a posative indication of an approval and are moving forward. Working out the next steps...and there are a multitude of them will unfold in the next few weeks. What kind of distribution/royalty/sales is part of the workout. Is it a buyout? At first I thought so, now, I'm not so sure. It may be just the normal sequence of things that were planned when a approval or 700 dose numbers came out. They have to plan for these events and something was triggered.
"CytoDyn Announces Leadership Transition Plan to Support Regulatory Approval and Commercialization of Leronlimab"